Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Lefra 20mg Tablets | 100-Count | LEFLUNOMIDE
Autoimmune & Anti-InflammatoryPharma

Lefra 20mg Tablets | 100-Count | LEFLUNOMIDE

$140

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse LEFLUNOMIDE — 20mg per tablet, 100-count pack. DMARD for rheumatoid arthritis and psoriatic arthritis. Second-line after methotrexate failure or intolerance. Once-daily dosing due to long half-life of active metabolite. Key warning: TERATOGENIC — pregnancy absolutely contraindicated. Accelerated elimination procedure (cholestyramine) required before pregnancy. Hepatotoxicity monitoring — especially combined with methotrexate.

SKU
VES-005540-LEFRA-20MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Lefra 20mg (LEFLUNOMIDE)?

DMARD for rheumatoid arthritis and psoriatic arthritis. Second-line after methotrexate failure or intolerance. Once-daily dosing due to long half-life of active metabolite.

How it Works

Prodrug converted to teriflunomide — inhibits DHODH, blocking de novo pyrimidine synthesis in proliferating T and B cells — reduces immune-mediated joint inflammation.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
LEFLUNOMIDE
Dose per Tablet
20MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Diarrhea (most common), nausea, hair loss (usually mild), rash, elevated liver enzymes, hypertension, peripheral neuropathy (rare).

Safety Warnings

TERATOGENIC — pregnancy absolutely contraindicated. Accelerated elimination procedure (cholestyramine) required before pregnancy. Hepatotoxicity monitoring — especially combined with methotrexate. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.